Article
Extended single-dose toxicity study of [211At]meta-astatobenzylguanidine in normal mice in preparation for the first-in-human clinical trial of targeted alpha therapy for pheochromocytoma and paraganglioma
2025-04-24
Abstract excerpt
<title>Abstract</title> <p>Objective Targeted alpha-particle therapy (TAT) is promising with a greater therapeutic effect than conventional beta radionuclide therapy. To develop human clinical trials of [<sup>211</sup>At]<italic>meta</italic>-astatobenzylguanidine ([<sup>211</sup>At]MABG), we have conducted an extended single-dose toxicity study of [<sup>211</sup>At]MABG in normal mice in consultation with the P...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 03c22a4c-ae90-577e-b52d-04e9b97253dc
- DOI
- 10.21203/rs.3.rs-6059261/v1
